Diabetes
The Wild and Woolly World of Anti-VEGF in 2023
A once-simple treatment protocol has gotten more sophisticated—and complicated—by novel drug compounds, varied dosing regimens and sustained-release delivery methods. Here’s the current state of affairs.
09/15/2023
Corneal Sensitivity Impaired in PDR Eyes, Not Reversed With Anti-VEGF Therapy
Assessment should be a standard screening test, as it may identify patients at risk for additional complications, such as diabetic keratopathy.
09/01/2023
Diabetes Sufferers Without Ocular Involvement Lag Behind in Routine Eyecare
While those with vision difficulty are better connected to eye care, significant disparities in this field persist for marginalized groups in the US.
08/29/2023
Psoriasis a Risk Factor for RVO in Diabetes Patients
The disease’s systemic inflammatory state and elevated risk of vascular complications may have ocular consequences, study shows.
08/28/2023
Risk Factors For DR Progression Found in Pregnant Women
Type of diabetes, HbA1c level at onset of pregnancy, gestational age, hypertension status and intravitreal injection history during pregnancy all showed to be risk factors.
08/17/2023
DR Risk Reduction Reflected in New Public Health Education Measurement
The American Heart Association’s updated cardiovascular assessment tool known as “Life’s Essential 8” shows promise for improving preventative strategies for diabetes and, with it, diabetic eye disease.
08/17/2023
Curtail Anti-VEGF in DME Patients with Subpar Response After Six Months
A new study also found better baseline VA predicts favorable results, though patients with worse initial acuity did show greater gains overall.
08/11/2023
White Blood Cells May Be Useful DME Biomarkers
Inflammatory indexes obtained via CBC could be an inexpensive way to guide treatment.
08/08/2023
Diabetic Neovascularization and Capillary Nonperfusion Follow Asymmetric Pattern
Study using ultra-widefield angiography finds the former predominates superotemporally while the latter are concentrated in the superonasal quadrant.
08/08/2023
Depression Somewhat Prevalent in Moderate to Severe NPDR Patients
Further education about the disease and more screening may reverse the initial increased rate of depression.
07/27/2023
Upcoming Events
September 27, 2023
Showcasing Inflammation and IOP Control
Location: Canaletto, Las Vegas, NV
Presenters: Derek Cunningham, OD, and Jessica Steen, OD
Presentation: 7:00 PM PT
Sponsored by Bausch + Lomb
October 3, 2023
Addressing a Major Gap in the Treatment of Dry Eye Disease
Location: Virtual
Presenters: Damon Dierker, OD, and Jennifer Loh, MD
Webinar: 8:00pm ET
Sponsored by Bausch + Lomb
October 5, 2023
Addressing a Major Gap in the Treatment of Dry Eye Disease
Location: Virtual
Presenters: Mile Brujic, OD, and Sheri Rowen, MD
Webinar: 7:00pm ET
Sponsored by Bausch + Lomb
